Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride Capsules
Clinical trial NCT04967443 · COMPLETED
Trial details
- NCT number
- NCT04967443
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-22
- Primary completion
- 2022-02-15
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.